Description

1. Question: A patient presents with symptoms of depression and is prescribed an antidepressant. Which of the following best describes the mechanism of action of selective serotonin reuptake inhibitors (SSRIs)?
2. Question: A patient with a history of severe migraines that occur more than three times a month seeks preventive treatment. Which medication would be most appropriate for this patient based on the provided information?
3. Question: A patient with Parkinson’s disease has been prescribed levodopa/carbidopa for symptom management. The patient experiences frequent episodes of nausea and vomiting. Which intervention would be most appropriate to alleviate these adverse effects?
4. Question: A patient presents with a history of tonic-clonic and partial They report no history of absence seizures. Which antiseizure drug would be the most appropriate initial choice for their treatment?
5. Question: Which statement best reflects valproic acid’s role in seizure management?
6. Question: A patient with Parkinson’s disease complains of visual hallucinations and excessive daytime sleepiness. Which dopamine agonist is most likely responsible for these adverse effects?
7. Question: A 45-year-old patient presents to the clinic with a history of recurrent migraines. Despite trying over-the-counter medications, the patient experiences severe migraines that interfere with daily activities. Considering the patient’s medical history, which medication would be the most appropriate first-line treatment to abort an ongoing migraine attack?
8. Question: Which of the following is considered a monoamine neurotransmitter of the central nervous system?
9. Question: A 30-year-old male with primary generalized tonic-clonic seizures is prescribed carbamazepine and phenytoin for seizure control. Despite being compliant with both medications, he continues to experience breakthrough seizures. What is the most likely explanation for the lack of efficacy?
10. Question: What type of baseline data assessment is recommended before initiating levodopa combinations in patients with Parkinson’s disease?
11. Question: A patient presents with a history of various seizure types, including tonic- clonic, absence, and partial seizures. Which antiseizure drug would be the most appropriate initial choice for their treatment?
12. Question: A patient with a history of partial seizures presents with complaints of dizziness and blurred vision. They have been taking lamotrigine for the past six months. On examination, they are noted to have a rash on her trunk. Which of the following is the most appropriate action by the prescriber?
13. Question: Which type of drugs are primarily employed in the treatment of Parkinson’s disease?
14. Question: A patient with Parkinson’s disease requires adjunctive therapy to improve the efficacy of levodopa. Which catechol-O-methyltransferase (COMT) inhibitor is preferred due to its safety profile?
15. Question: Which of the following is a medical application of central nervous system drugs?
16. Question: A patient with mild Alzheimer’s disease is started on cholinesterase inhibitor Considering the patient’s preference for once-daily dosing and minimal gastrointestinal side effects, which medication would be the most appropriate choice?
17. Question: A patient with Parkinson’s disease is started on levodopa therapy. Which dietary consideration is most important to discuss with the patient to optimize drug absorption?
18. Question: A patient with epilepsy is being treated with phenytoin. Which laboratory value should be monitored regularly to ensure safe and effective therapy?
19. Question: A patient with Parkinson’s disease requires adjunctive therapy to improve the efficacy of levodopa. Which catechol-O-methyltransferase (COMT) inhibitor is preferred due to its safety profile?
20. Question: A patient with mild Alzheimer’s disease is started on cholinesterase inhibitor Considering the patient’s preference for once-daily dosing and minimal gastrointestinal side effects, which medication would be the most appropriate choice?